Perelman Vadim 4
Accession 0000921895-18-001764
Filed
May 17, 8:00 PM ET
Accepted
May 18, 7:31 PM ET
Size
23.2 KB
Accession
0000921895-18-001764
Insider Transaction Report
- Sale
Common Stock
2018-05-15$6.27/sh−25,000$156,750→ 391,842 total(indirect: By: Baker Street Capital L.P.)
- 7,314
Common Stock
- 12,461
Series A Warrants
Exercise: $20.63From: 2018-02-09Exp: 2028-02-09→ Common Stock (12,461 underlying) - 710,171(indirect: By: Baker Street Capital L.P.)
Series A Warrants
Exercise: $20.63From: 2018-02-09Exp: 2028-02-09→ Common Stock (710,171 underlying) - 103,952(indirect: By: Baskerville SPV, L.P.)
Series B Warrants
Exercise: $28.25From: 2018-02-09Exp: 2028-02-09→ Common Stock (103,952 underlying) - 76,897(indirect: By: Baskerville SPV, L.P.)
Common Stock
- 9,887
Series B Warrants
Exercise: $28.25From: 2018-02-09Exp: 2028-02-09→ Common Stock (9,887 underlying) - 563,506(indirect: By: Baker Street Capital L.P.)
Series B Warrants
Exercise: $28.25From: 2018-02-09Exp: 2028-02-09→ Common Stock (563,506 underlying) - 131,008(indirect: By: Baskerville SPV, L.P.)
Series A Warrants
Exercise: $20.63From: 2018-02-09Exp: 2028-02-09→ Common Stock (131,008 underlying)
- Sale
Common Stock
2018-05-15$6.27/sh−25,000$156,750→ 391,842 total(indirect: By: Baker Street Capital L.P.)
- 12,461
Series A Warrants
Exercise: $20.63From: 2018-02-09Exp: 2028-02-09→ Common Stock (12,461 underlying) - 9,887
Series B Warrants
Exercise: $28.25From: 2018-02-09Exp: 2028-02-09→ Common Stock (9,887 underlying) - 131,008(indirect: By: Baskerville SPV, L.P.)
Series A Warrants
Exercise: $20.63From: 2018-02-09Exp: 2028-02-09→ Common Stock (131,008 underlying) - 103,952(indirect: By: Baskerville SPV, L.P.)
Series B Warrants
Exercise: $28.25From: 2018-02-09Exp: 2028-02-09→ Common Stock (103,952 underlying) - 710,171(indirect: By: Baker Street Capital L.P.)
Series A Warrants
Exercise: $20.63From: 2018-02-09Exp: 2028-02-09→ Common Stock (710,171 underlying) - 7,314
Common Stock
- 76,897(indirect: By: Baskerville SPV, L.P.)
Common Stock
- 563,506(indirect: By: Baker Street Capital L.P.)
Series B Warrants
Exercise: $28.25From: 2018-02-09Exp: 2028-02-09→ Common Stock (563,506 underlying)
- Sale
Common Stock
2018-05-15$6.27/sh−25,000$156,750→ 391,842 total(indirect: By: Baker Street Capital L.P.)
- 12,461
Series A Warrants
Exercise: $20.63From: 2018-02-09Exp: 2028-02-09→ Common Stock (12,461 underlying) - 563,506(indirect: By: Baker Street Capital L.P.)
Series B Warrants
Exercise: $28.25From: 2018-02-09Exp: 2028-02-09→ Common Stock (563,506 underlying) - 9,887
Series B Warrants
Exercise: $28.25From: 2018-02-09Exp: 2028-02-09→ Common Stock (9,887 underlying) - 710,171(indirect: By: Baker Street Capital L.P.)
Series A Warrants
Exercise: $20.63From: 2018-02-09Exp: 2028-02-09→ Common Stock (710,171 underlying) - 7,314
Common Stock
- 76,897(indirect: By: Baskerville SPV, L.P.)
Common Stock
- 131,008(indirect: By: Baskerville SPV, L.P.)
Series A Warrants
Exercise: $20.63From: 2018-02-09Exp: 2028-02-09→ Common Stock (131,008 underlying) - 103,952(indirect: By: Baskerville SPV, L.P.)
Series B Warrants
Exercise: $28.25From: 2018-02-09Exp: 2028-02-09→ Common Stock (103,952 underlying)
- Sale
Common Stock
2018-05-15$6.27/sh−25,000$156,750→ 391,842 total(indirect: By: Baker Street Capital L.P.)
- 710,171(indirect: By: Baker Street Capital L.P.)
Series A Warrants
Exercise: $20.63From: 2018-02-09Exp: 2028-02-09→ Common Stock (710,171 underlying) - 131,008(indirect: By: Baskerville SPV, L.P.)
Series A Warrants
Exercise: $20.63From: 2018-02-09Exp: 2028-02-09→ Common Stock (131,008 underlying) - 7,314
Common Stock
- 76,897(indirect: By: Baskerville SPV, L.P.)
Common Stock
- 9,887
Series B Warrants
Exercise: $28.25From: 2018-02-09Exp: 2028-02-09→ Common Stock (9,887 underlying) - 12,461
Series A Warrants
Exercise: $20.63From: 2018-02-09Exp: 2028-02-09→ Common Stock (12,461 underlying) - 103,952(indirect: By: Baskerville SPV, L.P.)
Series B Warrants
Exercise: $28.25From: 2018-02-09Exp: 2028-02-09→ Common Stock (103,952 underlying) - 563,506(indirect: By: Baker Street Capital L.P.)
Series B Warrants
Exercise: $28.25From: 2018-02-09Exp: 2028-02-09→ Common Stock (563,506 underlying)
- Sale
Common Stock
2018-05-15$6.27/sh−25,000$156,750→ 391,842 total(indirect: By: Baker Street Capital L.P.)
- 7,314
Common Stock
- 76,897(indirect: By: Baskerville SPV, L.P.)
Common Stock
- 12,461
Series A Warrants
Exercise: $20.63From: 2018-02-09Exp: 2028-02-09→ Common Stock (12,461 underlying) - 563,506(indirect: By: Baker Street Capital L.P.)
Series B Warrants
Exercise: $28.25From: 2018-02-09Exp: 2028-02-09→ Common Stock (563,506 underlying) - 131,008(indirect: By: Baskerville SPV, L.P.)
Series A Warrants
Exercise: $20.63From: 2018-02-09Exp: 2028-02-09→ Common Stock (131,008 underlying) - 103,952(indirect: By: Baskerville SPV, L.P.)
Series B Warrants
Exercise: $28.25From: 2018-02-09Exp: 2028-02-09→ Common Stock (103,952 underlying) - 9,887
Series B Warrants
Exercise: $28.25From: 2018-02-09Exp: 2028-02-09→ Common Stock (9,887 underlying) - 710,171(indirect: By: Baker Street Capital L.P.)
Series A Warrants
Exercise: $20.63From: 2018-02-09Exp: 2028-02-09→ Common Stock (710,171 underlying)
Footnotes (3)
- [F1]This Form 4 is filed jointly by Baker Street Capital L.P. ("BSC LP"), Baskerville SPV, L.P. ("Baskerville SPV"), Baker Street Capital GP, LLC ("BSC GP"), Baker Street Capital Management, LLC ("Baker Street Capital Management") and Vadim Perelman (collectively, the "Reporting Persons"). Each Reporting Person may be deemed to be a member of a Section 13(d) group that owns more than 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the shares of Common Stock reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such shares of Common Stock for purposes of Section 16 or for any other purpose.
- [F2]Represents securities owned directly by BSC LP. BSC GP, as the general partner of BSC LP, may be deemed to beneficially own the securities owned by BSC LP. Baker Street Capital Management, as the investment manager of BSC LP, may be deemed to beneficially own the securities owned by BSC LP. Mr. Perelman, as the managing member of each of BSC GP and Baker Street Capital Management, may be deemed to beneficially own the securities owned by BSC LP.
- [F3]Represents securities owned directly by Baskerville SPV. BSC GP, as the general partner of Baskerville SPV, may be deemed to beneficially own the securities owned by Baskerville SPV. Baker Street Capital Management, as the investment manager of Baskerville SPV, may be deemed to beneficially own the securities owned by Baskerville SPV. Mr. Perelman, as the managing member of each of BSC GP and Baker Street Capital Management, may be deemed to beneficially own the securities owned by Baskerville SPV.
Documents
Issuer
DITECH HOLDING Corp
CIK 0001040719
Related Parties
1- filerCIK 0001489810
Filing Metadata
- Form type
- 4
- Filed
- May 17, 8:00 PM ET
- Accepted
- May 18, 7:31 PM ET
- Size
- 23.2 KB